Literature DB >> 11696051

Safety of sputum induction with isotonic saline in adults with acute severe asthma.

P A Wark1, J L Simpson, M J Hensley, P G Gibson.   

Abstract

BACKGROUND: Sputum induction is a safe and effective technique to study airway inflammation in stable asthma. However, it has the potential to induce bronchospasm and the safety and efficacy of the technique in acute asthma has not been determined.
OBJECTIVE: The objective of this study was to evaluate the safety and efficacy of a protocol to induce sputum using isotonic saline in adults with acute exacerbations of asthma.
METHODS: Adults (n = 47) presenting to the emergency room with acute asthma and an FEV1 > 1.0 L underwent supervised sputum induction with 0.9% saline delivered by an ultrasonic nebuliser. Induction was ceased if there was a fall of 20% or greater from baseline FEV1.
RESULTS: Subjects had moderate to severe exacerbations of acute asthma. An adequate sputum sample was obtained in 87% of subjects. Four subjects ceased induction because of symptom distress. There was a fall > or = 20% in 28% of subjects. Bronchoconstriction was successfully reversed by salbutamol in all subjects. Predictors of significant bronchoconstriction were older age, use of ingested corticosteroids, and a requirement for high-dose nebulized salbutamol for the exacerbation. Maintenance long-acting beta2-agonist therapy protected against bronchoconstriction during sputum induction.
CONCLUSIONS: Sputum induction in acute asthma using isotonic saline is highly efficacious in obtaining an adequate sputum sample. There is the potential for significant bronchoconstriction to occur but this can be managed safely with minimal discomfort to subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696051     DOI: 10.1046/j.1365-2222.2001.01230.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  13 in total

1.  Safety of sputum induction with hypertonic saline solution in exercise-induced bronchoconstriction.

Authors:  Chris Carlsten; Moira L Aitken; Teal S Hallstrand
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

2.  Hydrogen peroxide in exhaled breath condensate (EBC) vs eosinophil count in induced sputum (IS) in parenchymal vs airways lung diseases.

Authors:  Elizabeth Fireman; Moshe Shtark; Israel E Priel; Robert Shiner; Ram Mor; Shmuel Kivity; Zvi Fireman
Journal:  Inflammation       Date:  2007-04       Impact factor: 4.092

3.  A modified nebulization modality versus classical ultrasonic nebulization and oxygen-driven nebulization in facilitating airway clearance in patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Qiaoling Luo; Zeguang Zheng; Huihong Cen; Mei Jiang; Qin Chen
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

4.  Dyspnea assessment and adverse events during sputum induction in COPD.

Authors:  Demosthenes Makris; Nikolaos Tzanakis; Joanna Moschandreas; Nikolaos M Siafakas
Journal:  BMC Pulm Med       Date:  2006-06-29       Impact factor: 3.317

5.  Determinants Of Oral corticosteroid Responsiveness in Wheezing Asthmatic Youth (DOORWAY): protocol for a prospective multicentre cohort study of children with acute moderate-to-severe asthma exacerbations.

Authors:  F M Ducharme; R Zemek; J Gravel; D Chalut; N Poonai; S Laberge; C Quach; M Krajinovic; C Guimont; C Lemière; M C Guertin
Journal:  BMJ Open       Date:  2014-04-07       Impact factor: 2.692

6.  Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.

Authors:  Solveig Tangedal; Marianne Aanerud; Louise J P Persson; Karl A Brokstad; Per S Bakke; Tomas M Eagan
Journal:  Respir Res       Date:  2014-11-15

7.  Isotonic Saline Nebulization and Lung Function in Children With Mild Respiratory Ailments.

Authors:  P Barski; M Surdacki; A Saj; A Wróblewska; M Ornat; A Pawelak; D Pompa; J Jurgiel; V Ermisch; A Hirnle; I Pirogowicz; I Stanisławska; M Łyp; M Pokorski
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

Review 8.  Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.

Authors:  Noora Louhelainen; Marjukka Myllärniemi; Irfan Rahman; Vuokko L Kinnula
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

9.  Validity of the common cold questionnaire (CCQ) in asthma exacerbations.

Authors:  Heather Powell; Joanne Smart; Lisa G Wood; Terry Grissell; Darren R Shafren; Michael J Hensley; Peter G Gibson
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

10.  Is nebulized saline a placebo in COPD?

Authors:  Shahina Y Khan; B Ronan O'Driscoll
Journal:  BMC Pulm Med       Date:  2004-09-30       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.